BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21989054)

  • 21. Notch-1 regulates cell death independently of differentiation in murine erythroleukemia cells through multiple apoptosis and cell cycle pathways.
    Jang MS; Miao H; Carlesso N; Shelly L; Zlobin A; Darack N; Qin JZ; Nickoloff BJ; Miele L
    J Cell Physiol; 2004 Jun; 199(3):418-33. PubMed ID: 15095289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
    Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of E-cadherin reduces bcl-2 expression and increases sensitivity to etoposide-induced apoptosis.
    Sasaki CY; Lin Hc; Passaniti A
    Int J Cancer; 2000 Jun; 86(5):660-6. PubMed ID: 10797287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells.
    Vizirianakis IS; Chen YQ; Kantak SS; Tsiftsoglou AS; Kramer RH
    Int J Oncol; 2002 Jul; 21(1):135-44. PubMed ID: 12063560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
    Walker A; Taylor ST; Hickman JA; Dive C
    Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines.
    Menke A; Philippi C; Vogelmann R; Seidel B; Lutz MP; Adler G; Wedlich D
    Cancer Res; 2001 Apr; 61(8):3508-17. PubMed ID: 11309315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rac1 and Rho contribute to the migratory and invasive phenotype associated with somatic E-cadherin mutation.
    Deplazes J; Fuchs M; Rauser S; Genth H; Lengyel E; Busch R; Luber B
    Hum Mol Genet; 2009 Oct; 18(19):3632-44. PubMed ID: 19584084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
    Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
    Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helenalin bypasses Bcl-2-mediated cell death resistance by inhibiting NF-κB and promoting reactive oxygen species generation.
    Hoffmann R; von Schwarzenberg K; López-Antón N; Rudy A; Wanner G; Dirsch VM; Vollmar AM
    Biochem Pharmacol; 2011 Sep; 82(5):453-63. PubMed ID: 21669190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts.
    Kuphal F; Behrens J
    Exp Cell Res; 2006 Feb; 312(4):457-67. PubMed ID: 16368435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemopreventive alteration of the cell-cell adhesion in head and neck squamous cell cancer.
    Naim R; Chang RC; Schultz J; Hormann K
    Oncol Rep; 2006 Aug; 16(2):273-7. PubMed ID: 16820902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of apoptosis in cultured endothelial cells by a cadherin antagonist peptide: involvement of fibroblast growth factor receptor-mediated signalling.
    Erez N; Zamir E; Gour BJ; Blaschuk OW; Geiger B
    Exp Cell Res; 2004 Apr; 294(2):366-78. PubMed ID: 15023527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanism and significance of E-cadherin, anti-apoptosis B-cell lymphoma-2 protein and sE-cadherin roles in cancer.
    Liu L; Li HX; Lv XQ
    J Biol Regul Homeost Agents; 2014; 28(4):683-91. PubMed ID: 25620178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Notch pathway is activated by MAPK signaling and influences papillary thyroid cancer proliferation.
    Yamashita AS; Geraldo MV; Fuziwara CS; Kulcsar MA; Friguglietti CU; da Costa RB; Baia GS; Kimura ET
    Transl Oncol; 2013 Apr; 6(2):197-205. PubMed ID: 23544172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triptolide, a Cancer Cell Proliferation Inhibitor, Causes Zebrafish Muscle Defects by Regulating Notch and STAT3 Signaling Pathways.
    Lee B; Park Y; Lee Y; Kwon S; Shim J
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the Axis β-Catenin-BTK in the Dynamic Adhesion of Chronic Lymphocytic Leukemia Cells to Their Microenvironment.
    Mihoub I; Rharass T; Ouriemmi S; Oudar A; Aubard L; Gratio V; Lazarian G; Ferreira J; Dondi E; Cymbalista F; Levy V; Baran-Marszak F; Varin-Blank N; Ledoux D; Le Roy C; Gardano L
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current advances in understanding the molecular profile of hereditary diffuse gastric cancer and its clinical implications.
    Lim HJ; Zhuang L; Fitzgerald RC
    J Exp Clin Cancer Res; 2023 Mar; 42(1):57. PubMed ID: 36869400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Notch-associated lncRNAs profiling circuiting epigenetic modification in colorectal cancer.
    Emam O; Wasfey EF; Hamdy NM
    Cancer Cell Int; 2022 Oct; 22(1):316. PubMed ID: 36229883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Association of CDH1, FANCB and APC Gene Polymorphisms 
with Lung Cancer Susceptibility in Chinese Population].
    Su L; Huang H; Gao M; Li Y; Shi R; Chen C; Li X; Zhu G; Liu H; Chen J
    Zhongguo Fei Ai Za Zhi; 2022 Sep; 25(9):658-664. PubMed ID: 36172730
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model.
    Yamaguchi K; Yoshihiro T; Ariyama H; Ito M; Nakano M; Semba Y; Nogami J; Tsuchihashi K; Yamauchi T; Ueno S; Isobe T; Shindo K; Moriyama T; Ohuchida K; Nakamura M; Nagao Y; Ikeda T; Hashizume M; Konomi H; Torisu T; Kitazono T; Kanayama T; Tomita H; Oda Y; Kusaba H; Maeda T; Akashi K; Baba E
    Gastric Cancer; 2022 Sep; 25(5):862-878. PubMed ID: 35661943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.